NCT02916628

Brief Summary

Objective The purpose of this study is to examine the effects of auricular acupressure and group counseling with positive psychology and motivational interviewing on smoking cessation and tobacco withdrawal symptoms. Methods This study is a single blind randomized controlled trial. This study has been performed at a University in South Korea. 180 smokers and 60 non-smokers will be recruited. Smokers will be randomly assigned to three groups: group 1 (auricular acupressure + group counseling); group 2 (placebo acupressure + group counseling); and the control group (self-help smoking cessation). Group counseling is undertaken once per week for 6 weeks. Auricular acupressure using acupellets is performed for 6 weeks continuously.

Trial Health

57
Monitor

Trial Health Score

Automated assessment based on enrollment pace, timeline, and geographic reach

Enrollment
225

participants targeted

Target at P75+ for not_applicable

Timeline
Completed

Started Jul 2013

Longer than P75 for not_applicable

Geographic Reach
1 country

1 active site

Status
terminated

Health score is calculated from publicly available data and should be used for screening purposes only.

Trial Relationships

Click on a node to explore related trials.

Study Timeline

Key milestones and dates

Study Start

First participant enrolled

July 1, 2013

Completed
3.2 years until next milestone

First Submitted

Initial submission to the registry

September 20, 2016

Completed
7 days until next milestone

First Posted

Study publicly available on registry

September 27, 2016

Completed
4 months until next milestone

Primary Completion

Last participant's last visit for primary outcome

February 1, 2017

Completed
2.8 years until next milestone

Study Completion

Last participant's last visit for all outcomes

December 1, 2019

Completed
Last Updated

February 10, 2021

Status Verified

February 1, 2021

Enrollment Period

3.6 years

First QC Date

September 20, 2016

Last Update Submit

February 8, 2021

Conditions

Keywords

smoking cessationgroup counselingacupressureserotonindepressive symptomsresilience

Outcome Measures

Primary Outcomes (5)

  • smoking cessation: Change from Baseline Smoking status at 3,6 months, 1 year, 2 years

    self-report

    baseline, 6 weeks, 3 months, 6 months, 1 year, 2 years

  • Minnesota Tobacco Withdrawal Scale(MTWS):Change from Baseline tobacco withdrawal symptoms at 2,3,4,5,6 weeks

    The MTWS was developed to measure nicotine withdrawal symptoms \[22\]. The MTWS consists of nine items with a 4-point Likert scale. Higher scores indicate more severe withdrawal symptoms. Cronbach's alpha was .88 in 118 Korean Americans. Factor analysis showed two factors: mental difficulties and physical difficulties. These two factors explained 66% of the variance

    baseline,2,3,4,5,6 weeks

  • multidimensional coping scale: Change from Baseline coping skills at 6 weeks, 6 months, 1 year, 2 years

    The multidimensional coping scale was developed by Jeon, KG(1994). It consists 50 items including personal, social, and religious coping. The multidimensional coping scale is composed of personal, social, and religious coping resources: (Personal Coping Resources), active coping, passive withdrawal, emotional expression, active forgetting, perseverance, positive interpretation, positive comparison, accommodation, fatalism, self-criticism, emotional pacification; (Social Coping Resources), problem-solving social support seeking, emotional social support seeking; (Religious Coping Resources), religious seeking.

    baseline, 6 weeks, 6 months, 1 year, 2 years

  • urine cotinine test:Change from 6-week urine cotinine at 6 months, 1 year, 2 years

    Cotinine is the first-stage metabolite of nicotine. The urine cotinine test using a fresh urine specimen was used to check smoking cessation. There was neither any benefit for smoking cessation in this study nor any legal problem to smoking cigarettes in South Korea. Therefore, participants were allowed to provide urine specimens without close monitoring. The urine cotinine test is a rapid, one-step, immunochromatographic assay for the qualitative detection of cotinine in human urine at 200 ng/ml cut-off concentration. Three drops of urine were transferred to the urine cotinine test apparatus (Brand name: Lungene one step rapid test, Company: Hangzhou Clongene Biotech Co., Ltd, made in China). Two lines indicated a negative result, while one line indicated a positive result. For participants who did not smoke for at least one week, negative test results were expected. Urine cotinine was checked at the 6-week post-test and 6-month follow-up.

    6 weeks, 6 months, 1 year, 2 years

  • serum cotinine levels:Change from 6-week serum cotinine levels at 6 months, 1 year, 2 years

    Serum cotinine levels reflect recent exposure to nicotine in tobacco smoke. Nonsmoking is usually defined as a serum cotinine level of less than or equal to 10 ng/mL (Pirkle et al., 1996).

    6 weeks, 6 months, 1 year, 2 years

Secondary Outcomes (4)

  • Patient Health Questionnaire-9

    6 weeks, 6 months, 1 year, 2 years

  • Resilience

    6 weeks, 6 months, 1 year, 2 years

  • Serum serotonin

    6 weeks, 6 months, 1 year, 2 years

  • Eysenck Personality Inventory

    baseline

Study Arms (4)

Group 1

EXPERIMENTAL

auricular acupressure + group counseling

Behavioral: group counselingDevice: Auricular acupressure

Group 2

PLACEBO COMPARATOR

placebo acupressure + group counseling

Behavioral: group counselingDevice: placebo acupressure

Group 3

NO INTERVENTION

self-help smoking cessation

Group 4

NO INTERVENTION

Non-smokers

Interventions

Group counseling with positive psychology and motivational interviewing was undertaken once per week for 6 weeks.

Group 1Group 2

Auricular acupressure using acupellets was performed for 6 weeks continuously

Group 1

Placebo acupellets were prepared without metal projections, and placed on both sides in the same areas of the ear as the active condition.

Group 2

Eligibility Criteria

Age19 Years+
Sexall
Healthy VolunteersYes
Age GroupsAdult (18-64), Older Adult (65+)

You may qualify if:

  • smokers who:
  • were more than 19 years
  • could complete questionnaires
  • have smoked longer than 6 months
  • wanted to quit smoking cigarettes
  • did not have an infection on the surface of the ears.

You may not qualify if:

  • smokers who
  • were using nicotine patches or medications for smoking cessation
  • had allergies to copper or aluminum
  • had used illegal drugs
  • were pregnant.

Contact the study team to confirm eligibility.

Sponsors & Collaborators

Study Sites (1)

Inha University Hospital

Incheon, South Korea

Location

MeSH Terms

Conditions

SmokingSmoking CessationDepression

Condition Hierarchy (Ancestors)

BehaviorHealth BehaviorBehavioral Symptoms

Study Design

Study Type
interventional
Phase
not applicable
Allocation
RANDOMIZED
Masking
DOUBLE
Who Masked
PARTICIPANT, INVESTIGATOR
Purpose
TREATMENT
Intervention Model
PARALLEL
Sponsor Type
OTHER
Responsible Party
PRINCIPAL INVESTIGATOR
PI Title
Associate professor

Study Record Dates

First Submitted

September 20, 2016

First Posted

September 27, 2016

Study Start

July 1, 2013

Primary Completion

February 1, 2017

Study Completion

December 1, 2019

Last Updated

February 10, 2021

Record last verified: 2021-02

Locations